Clinical Orthopaedics and Related Research®

, Volume 468, Issue 7, pp 1765–1772

Prevalence and Predictors of Osteoporosis Risk in Orthopaedic Patients

  • Tamara D. Rozental
  • Jalaal Shah
  • Aron T. Chacko
  • David Zurakowski
Symposium: Gender-specific Issues in Orthopaedic Surgery

Abstract

Background

Current physician practices are not effective in adequately evaluating and treating patients for osteoporosis. While dual-energy xray absorptiometry is the gold standard in evaluating bone mineral density, calcaneal quantitative ultrasound has emerged as a low-risk and low-cost alternative.

Questions/purposes

We estimated the prevalence of abnormal bone mineral density with calcaneal quantitative ultrasound and developed criteria for risk stratification in female and male orthopaedic patients.

Methods

We enrolled 500 patients (331 women, 169 men) with a mean age of 67 years (range, 55–94 years) and screened them for osteoporosis with calcaneal quantitative ultrasound. Multivariate logistic regression was used to identify predictors of low bone mineral density and a risk model was developed.

Results

Quantitative ultrasound identified 154 patients with low bone mineral density at the time of enrollment. The prevalence of abnormal bone mineral density was 31% (women: 38%, men: 17%). Multivariate analysis demonstrated age, female gender, smoking, wrist fracture, and spinal deformities independently predicted low bone mineral density. The probability of low bone mineral density among patients with more than one risk factor was greater than 50% among women and greater than 30% among men.

Conclusions

Low bone mineral density is common among orthopaedic outpatients. Age, female gender, smoking, wrist fractures, and spinal deformities are independent risk factors for osteoporosis. We present a probability model designed to assist orthopaedic surgeons in identifying high-risk patients and initiating adequate preventative measures.

Level of Evidence

Level I, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.

References

  1. 1.
    Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, Tao JL, Cummings SR. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1993;118:657–665.PubMedGoogle Scholar
  2. 2.
    Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1997;157:629–634.CrossRefPubMedGoogle Scholar
  3. 3.
    Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809–1822.CrossRefPubMedGoogle Scholar
  4. 4.
    Centers for Medicare and Medicaid Services Web site. Available at: http://www.cms.hhs.gov/PFSlookup/02_PFSSearch.asp#TopOfPage. Accessed September 8, 2009.
  5. 5.
    Clinton J, Franta A, Polissar NL, Neradilek B, Mounce D, Fink HA, Schousboe JT, Matsen FA III. Proximal humerus fracture as a risk factor for subsequent hip fractures. J Bone Joint Surg Am. 2009;91:503–511.CrossRefPubMedGoogle Scholar
  6. 6.
    Cooper C, Melton LJ III. Epidemiology of osteoporosis. Trends Endocrinol Metab. 1992;3:224–229.CrossRefPubMedGoogle Scholar
  7. 7.
    Cuddihy MT, Gabriel SE, Crowson CS, O’Fallon WM, Melton LJ III. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int. 1999;9:469–475.PubMedGoogle Scholar
  8. 8.
    Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282:637–645.CrossRefPubMedGoogle Scholar
  9. 9.
    Freedman K, Kaplan F, Bilker W, Strom B, Lowe R. Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am. 2000;82:1063–1070.PubMedGoogle Scholar
  10. 10.
  11. 11.
    Grabe DW, Cerulli J, Stroup JS, Kane MP. Comparison of the Achilles Express ultrasonometer with central dual-energy x-ray absorptiometry. Ann Pharmacother. 2006;40:830–836.CrossRefPubMedGoogle Scholar
  12. 12.
    Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet. 1996;348:511–514.CrossRefPubMedGoogle Scholar
  13. 13.
    Harrell FE, Lee KL, Mark DB. Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387.CrossRefPubMedGoogle Scholar
  14. 14.
    Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH III, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Group. JAMA. 1999;282:1344–1352.CrossRefPubMedGoogle Scholar
  15. 15.
    Hosam KK, Hussain MS, Tariq S, Perry HM III, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fractures. Am J Med. 2000;109;326–328.CrossRefGoogle Scholar
  16. 16.
    Huopio J, Kröger H, Honkanen R, Jurvelin J, Saarikoski S, Alhava E. Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD: a prospective study of 422 women. Osteoporos Int. 2004;15:190–195.CrossRefPubMedGoogle Scholar
  17. 17.
    Kanis JA. Risk stratification. In: Cooper C, Gehlbach SH, Lindsay R, eds. Prevention and Treatment of Osteoporosis. London, UK: Informa; 2005:43–56.Google Scholar
  18. 18.
    Karpf D, Shapiro D, Seeman E, Ensrud K, Johnston C, Conrad C, Silvano A, Harris S, Santora A, Hirsch L, Oppenheimer L, Thompson D. Prevention of nonvertebral fractures by alendronate: a meta-analysis. JAMA. 1997;277:1159–1164.CrossRefPubMedGoogle Scholar
  19. 19.
    Katz MH. Multivariable Analysis: A Practical Guide for Clinicians. 2nd ed. Cambridge, UK: Cambridge University Press; 2006:96–116.Google Scholar
  20. 20.
    Khaw KT, Reeve J, Luben R, Bingham S, Welch A, Wareham N, Oakes S, Day N. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet. 2004;363:197–202.CrossRefPubMedGoogle Scholar
  21. 21.
    Lauritzen JB, Schwarz P, McNair P, Lund B, Transbol I. Radial and humeral fractures are predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation. Osteoporos Int. 1993;3:133–137.CrossRefPubMedGoogle Scholar
  22. 22.
    Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int. 1993;52:269–272.CrossRefPubMedGoogle Scholar
  23. 23.
    The National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov/nchs/nhanes.htm. Accessed September 9, 2009.
  24. 24.
    National Osteoporosis Foundation. Available at: http://www.nof.org. Accessed September 9, 2009.
  25. 25.
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434–1441.CrossRefPubMedGoogle Scholar
  26. 26.
    Reginster J, Deroisy R, Lecart M, Sarlet N, Zegels B, Jupsin I, Longueville M, Franchimont P. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss. Am J Med. 1995;98:452–458.CrossRefPubMedGoogle Scholar
  27. 27.
    Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327:620–627.CrossRefPubMedGoogle Scholar
  28. 28.
    Rozental TD, Makhni EC, Day CS, Bouxsein ML. Improving evaluation and treatment for osteoporosis following distal radial fractures: a prospective randomized intervention. J Bone Joint Surg Am. 2008;90:953–961.CrossRefPubMedGoogle Scholar
  29. 29.
    Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34:195–202.CrossRefPubMedGoogle Scholar
  30. 30.
    Smith MD, Ross W, Ahern MJ. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J Rheumatol. 2001;28:2504–2508.PubMedGoogle Scholar
  31. 31.
    Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR; Osteoporotic Fractures Research Group. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18:1947–1954.CrossRefPubMedGoogle Scholar
  32. 32.
    Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis. 1998;57:378–379.CrossRefPubMedGoogle Scholar
  33. 33.
    Trimpou P, Bosaeus I, Bengtsson BA, Landin-Wilhelmsen K. High correlation between quantitative ultrasound and DXA during 7 years of follow-up. Eur J Radiol. 2009 January 7 [Epub ahead of print].Google Scholar
  34. 34.
    Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–718.CrossRefPubMedGoogle Scholar
  35. 35.
    Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES; Study of Osteoporotic Fractures Research Group. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005;90:2787–2793.Google Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2009

Authors and Affiliations

  • Tamara D. Rozental
    • 1
  • Jalaal Shah
    • 2
  • Aron T. Chacko
    • 1
  • David Zurakowski
    • 3
  1. 1.Department of Orthopaedic Surgery, Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonUSA
  2. 2.Chicago College of Osteopathic MedicineMidwestern UniversityDowners GroveUSA
  3. 3.Department of Anesthesiology and Surgery, Childrens’ Hospital BostonHarvard Medical SchoolBostonUSA

Personalised recommendations